Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Seminoma | 4 | 2016 | 118 | 1.240 |
Why?
|
Testicular Neoplasms | 4 | 2016 | 769 | 0.840 |
Why?
|
Prostatic Neoplasms | 16 | 2021 | 10651 | 0.720 |
Why?
|
Pelvic Neoplasms | 1 | 2020 | 251 | 0.690 |
Why?
|
Brachytherapy | 3 | 2021 | 1288 | 0.600 |
Why?
|
Radiosurgery | 2 | 2022 | 1350 | 0.550 |
Why?
|
Orchiectomy | 2 | 2016 | 455 | 0.530 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2016 | 1841 | 0.430 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2016 | 3564 | 0.350 |
Why?
|
Radiotherapy Dosage | 6 | 2021 | 2955 | 0.320 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2016 | 8943 | 0.310 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2021 | 794 | 0.270 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6370 | 0.270 |
Why?
|
Quality of Life | 4 | 2021 | 11760 | 0.260 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 4 | 2013 | 1586 | 0.240 |
Why?
|
Urination Disorders | 2 | 2021 | 246 | 0.210 |
Why?
|
Watchful Waiting | 2 | 2015 | 457 | 0.190 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2021 | 323 | 0.190 |
Why?
|
Radiation Injuries | 2 | 2021 | 1226 | 0.180 |
Why?
|
Carcinoma, Renal Cell | 1 | 2014 | 2968 | 0.180 |
Why?
|
Cystectomy | 3 | 2013 | 632 | 0.170 |
Why?
|
Kidney Neoplasms | 1 | 2014 | 4046 | 0.160 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2013 | 2100 | 0.140 |
Why?
|
Cancer Care Facilities | 2 | 2014 | 415 | 0.130 |
Why?
|
Hospitals, Community | 1 | 2016 | 336 | 0.130 |
Why?
|
Neoplasm Staging | 7 | 2021 | 11200 | 0.120 |
Why?
|
Male | 26 | 2021 | 351380 | 0.110 |
Why?
|
Rectum | 2 | 2021 | 887 | 0.110 |
Why?
|
Medical Oncology | 2 | 2014 | 2125 | 0.110 |
Why?
|
Androgen Antagonists | 1 | 2020 | 1285 | 0.110 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12417 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1156 | 0.100 |
Why?
|
Nomograms | 1 | 2013 | 234 | 0.100 |
Why?
|
Disease-Free Survival | 4 | 2015 | 7056 | 0.100 |
Why?
|
Middle Aged | 17 | 2021 | 215041 | 0.100 |
Why?
|
Consumer Health Information | 1 | 2012 | 222 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6778 | 0.090 |
Why?
|
Aged | 15 | 2021 | 162856 | 0.090 |
Why?
|
Patient Care Management | 1 | 2013 | 319 | 0.090 |
Why?
|
Urinary Bladder | 2 | 2013 | 1139 | 0.090 |
Why?
|
Urologic Surgical Procedures | 1 | 2011 | 293 | 0.090 |
Why?
|
Epidemics | 1 | 2014 | 485 | 0.090 |
Why?
|
Referral and Consultation | 4 | 2014 | 3473 | 0.080 |
Why?
|
Aged, 80 and over | 5 | 2021 | 58528 | 0.080 |
Why?
|
Nephrectomy | 1 | 2014 | 1001 | 0.080 |
Why?
|
Photons | 1 | 2012 | 606 | 0.080 |
Why?
|
Odds Ratio | 3 | 2016 | 9974 | 0.080 |
Why?
|
Combined Modality Therapy | 3 | 2017 | 8923 | 0.080 |
Why?
|
Hospitals, General | 1 | 2011 | 715 | 0.080 |
Why?
|
Radiotherapy, Conformal | 1 | 2011 | 565 | 0.080 |
Why?
|
Humans | 27 | 2022 | 717237 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12483 | 0.070 |
Why?
|
Adult | 8 | 2021 | 212451 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 990 | 0.070 |
Why?
|
Radiotherapy | 1 | 2013 | 1623 | 0.070 |
Why?
|
Patient Education as Topic | 2 | 2012 | 2342 | 0.070 |
Why?
|
Disease Management | 1 | 2016 | 2537 | 0.070 |
Why?
|
Salvage Therapy | 1 | 2011 | 1303 | 0.070 |
Why?
|
Lymphatic Metastasis | 1 | 2013 | 2975 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 4954 | 0.060 |
Why?
|
Patient Care Team | 2 | 2013 | 2595 | 0.060 |
Why?
|
Insurance, Health | 1 | 2016 | 2498 | 0.060 |
Why?
|
Medicaid | 1 | 2016 | 2635 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2014 | 1866 | 0.060 |
Why?
|
Protons | 3 | 2013 | 1067 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 16017 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2013 | 2334 | 0.060 |
Why?
|
Prospective Studies | 4 | 2021 | 51275 | 0.060 |
Why?
|
Patient Participation | 1 | 2012 | 1477 | 0.060 |
Why?
|
Developing Countries | 1 | 2014 | 2732 | 0.050 |
Why?
|
Seminal Vesicles | 2 | 2011 | 106 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2022 | 8805 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39302 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2021 | 62348 | 0.050 |
Why?
|
Patient Compliance | 1 | 2012 | 2752 | 0.050 |
Why?
|
Databases, Factual | 1 | 2016 | 7847 | 0.050 |
Why?
|
Internet | 1 | 2012 | 3082 | 0.050 |
Why?
|
Neoplasm Invasiveness | 3 | 2013 | 3704 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2014 | 3031 | 0.050 |
Why?
|
Organs at Risk | 1 | 2021 | 341 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 12607 | 0.040 |
Why?
|
Young Adult | 2 | 2016 | 56247 | 0.040 |
Why?
|
Prostate-Specific Antigen | 2 | 2021 | 2281 | 0.040 |
Why?
|
Prognosis | 2 | 2014 | 29226 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2013 | 4872 | 0.040 |
Why?
|
Boston | 3 | 2014 | 9407 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 9577 | 0.030 |
Why?
|
Forefoot, Human | 1 | 2014 | 33 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1635 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2022 | 72614 | 0.030 |
Why?
|
Time Factors | 5 | 2017 | 41095 | 0.030 |
Why?
|
Qualitative Research | 2 | 2012 | 2547 | 0.030 |
Why?
|
Risk Factors | 6 | 2021 | 70864 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6805 | 0.030 |
Why?
|
Female | 6 | 2020 | 377909 | 0.030 |
Why?
|
Interinstitutional Relations | 1 | 2014 | 246 | 0.030 |
Why?
|
Hydronephrosis | 1 | 2013 | 275 | 0.030 |
Why?
|
Capacity Building | 1 | 2014 | 260 | 0.030 |
Why?
|
Botswana | 1 | 2014 | 980 | 0.030 |
Why?
|
Lactoglobulins | 1 | 1990 | 22 | 0.030 |
Why?
|
Receptors, Prolactin | 1 | 1990 | 16 | 0.030 |
Why?
|
Marital Status | 1 | 2012 | 441 | 0.030 |
Why?
|
Penis | 1 | 2011 | 218 | 0.020 |
Why?
|
Altruism | 1 | 2012 | 204 | 0.020 |
Why?
|
Advisory Committees | 1 | 2014 | 767 | 0.020 |
Why?
|
Femur Head | 1 | 2011 | 293 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1692 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 15672 | 0.020 |
Why?
|
United States | 1 | 2016 | 67798 | 0.020 |
Why?
|
Prolactin | 1 | 1990 | 676 | 0.020 |
Why?
|
Logistic Models | 2 | 2014 | 13601 | 0.020 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 563 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 2011 | 506 | 0.020 |
Why?
|
Reimbursement, Incentive | 1 | 2012 | 525 | 0.020 |
Why?
|
Risk Assessment | 3 | 2013 | 23542 | 0.020 |
Why?
|
Postoperative Care | 1 | 2013 | 1512 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2014 | 2142 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 20568 | 0.020 |
Why?
|
Adolescent | 1 | 2014 | 85139 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 2678 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 964 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2935 | 0.020 |
Why?
|
Patient Preference | 1 | 2012 | 859 | 0.020 |
Why?
|
Prostate | 1 | 2011 | 1604 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2014 | 1973 | 0.010 |
Why?
|
Motivation | 1 | 2012 | 1903 | 0.010 |
Why?
|
Transfection | 1 | 1990 | 6142 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2011 | 2572 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2013 | 3402 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 7001 | 0.010 |
Why?
|
Biopsy | 1 | 2012 | 6753 | 0.010 |
Why?
|
Patient Selection | 1 | 2012 | 4321 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 1990 | 6051 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13307 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10451 | 0.010 |
Why?
|
DNA | 1 | 1990 | 7166 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15271 | 0.010 |
Why?
|
Physicians | 1 | 2014 | 4354 | 0.010 |
Why?
|
Brain | 1 | 2022 | 25281 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18798 | 0.010 |
Why?
|
Cohort Studies | 1 | 2015 | 39887 | 0.010 |
Why?
|
Cricetinae | 1 | 1990 | 2597 | 0.000 |
Why?
|
Gene Expression | 1 | 1990 | 8013 | 0.000 |
Why?
|
Cell Line | 1 | 1990 | 16693 | 0.000 |
Why?
|
Animals | 1 | 1990 | 170890 | 0.000 |
Why?
|
Concepts
(145)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_